Changes in uterine artery Doppler velocimetry and circulating angiogenic factors in the first half of pregnancies delivering a small‐for‐gestational‐age neonate

To assess the relationship between longitudinal changes in placental Doppler indices and maternal circulating angiogenic factors in the first half of pregnancy and delivery of a small‐for‐gestational‐age (SGA) neonate, and ascertain whether longitudinal evaluation of these variables improves the prediction achieved by second‐trimester cross‐sectional evaluation.

[1]  E. Gratacós,et al.  First‐trimester screening with specific algorithms for early‐ and late‐onset fetal growth restriction , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  E. Gratacós,et al.  Contingent versus routine third‐trimester screening for late fetal growth restriction , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[3]  E. Gratacós,et al.  Angiogenic Factors and Doppler Evaluation in Normally Growing Fetuses at Routine Third-Trimester Scan: Prediction of Subsequent Low Birth Weight , 2015, Fetal Diagnosis and Therapy.

[4]  E. Gratacós,et al.  First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors , 2015, Prenatal diagnosis.

[5]  E. Contro,et al.  Uterine artery Doppler longitudinal changes in pregnancies complicated with intrauterine growth restriction without preeclampsia , 2014, Prenatal diagnosis.

[6]  A. Baschat,et al.  Second‐trimester prediction of delivery of a small‐for‐gestational‐age neonate: integrating sequential Doppler information, fetal biometry, and maternal characteristics , 2014, Prenatal diagnosis.

[7]  E. Gratacós,et al.  Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion. , 2014, Placenta.

[8]  N. Sebire,et al.  Placental Pathology in Early-Onset and Late-Onset Fetal Growth Restriction , 2014, Fetal Diagnosis and Therapy.

[9]  E. Ferrazzi,et al.  Perinatal morbidity and mortality in early‐onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE) , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[10]  A. Baschat,et al.  Emergence of Late-Onset Placental Dysfunction: Relationship to the Change in Uterine Artery Blood Flow Resistance between the First and Third Trimesters , 2012, American Journal of Perinatology.

[11]  P. Andraweera,et al.  The vascular endothelial growth factor family in adverse pregnancy outcomes. , 2012, Human reproduction update.

[12]  M. Ezzati,et al.  Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis , 2011, The Lancet.

[13]  R. Cruz‐Martínez,et al.  Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late‐onset small‐for‐gestational age fetuses , 2011, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[14]  François Audibert,et al.  Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy: A Meta-Analysis , 2010, Obstetrics and gynecology.

[15]  Bart Bijnens,et al.  Fetal Growth Restriction Results in Remodeled and Less Efficient Hearts in Children , 2010, Circulation.

[16]  G. Macones.  ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. , 2009, Obstetrics and gynecology.

[17]  F. Figueras,et al.  Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation , 2008, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[18]  Wenjiang J. Fu,et al.  A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[19]  Wenjiang J. Fu,et al.  The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[20]  Ariel J. Jaffa,et al.  Neurodevelopmental Outcome of Children With Intrauterine Growth Retardation: A Longitudinal, 10-Year Prospective Study , 2007, Journal of child neurology.

[21]  R. Levine,et al.  Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. , 2006, Hypertension.

[22]  E. Gratacós,et al.  Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. , 2006, American journal of obstetrics and gynecology.

[23]  Eugenia K. Pallotto,et al.  Perinatal Outcome and Later Implications of Intrauterine Growth Restriction , 2006, Clinical obstetrics and gynecology.

[24]  D. Barker,et al.  Adult Consequences of Fetal Growth Restriction , 2006, Clinical obstetrics and gynecology.

[25]  M. Dixon-Woods,et al.  Practices and views on fetal heart monitoring: a structured observation and interview study , 2006, BJOG : an international journal of obstetrics and gynaecology.

[26]  G. Dekker,et al.  Circulating Angiogenic Factors and Abnormal Uterine Artery Doppler Velocimetry in the Second Trimester , 2006, Hypertension in pregnancy.

[27]  R. Ness,et al.  Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. , 2005, The Journal of clinical endocrinology and metabolism.

[28]  P G Lindqvist,et al.  Does antenatal identification of small‐for‐gestational age fetuses significantly improve their outcome? , 2005, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[29]  A. Hunter,et al.  Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. , 2004, American journal of obstetrics and gynecology.

[30]  Jason Gardosi,et al.  Perinatal mortality and fetal growth restriction. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[31]  T. Mayhew.  Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. , 2002, Placenta.

[32]  J. Pezzullo,et al.  Prognostic value of uterine artery Doppler velocimetry in growth-restricted fetuses delivered near term. , 2002, American journal of obstetrics and gynecology.

[33]  J. Aarnoudse,et al.  Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. , 2001, Placenta.

[34]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[35]  A. Gregg,et al.  “Normal” Umbilical Arterial and Venous Acid—Base and Blood Gas Values , 1993, Clinical obstetrics and gynecology.

[36]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[37]  J. Hanley.  The Robustness of the "Binormal" Assumptions Used in Fitting ROC Curves , 1988, Medical decision making : an international journal of the Society for Medical Decision Making.

[38]  J. Fleming,et al.  A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTS , 1975, British journal of obstetrics and gynaecology.

[39]  G. Macones,et al.  Intrapartum Fetal Heart Rate Monitoring: Nomenclature, Interpretation, and General Management Principles , 2009 .

[40]  J Figueras,et al.  Customized birthweight standards for a Spanish population. , 2008, European journal of obstetrics, gynecology, and reproductive biology.

[41]  Robert N. Taylor,et al.  Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. , 2003, American journal of obstetrics and gynecology.

[42]  Gynecologists,et al.  Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. , 2001, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.